Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma [2]

Leukemia and Lymphoma

Volumn 48, Issue 10, 2007, Pages 2058-2059

  Xicoy, Blanca ^a   Ribera, Josep María ^a   Romeu, Joan ^a   Mate, José Luís ^b   Millà, Fuensanta ^a   Feliu, Evarist ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; LOPINAVIR; RITONAVIR;

ADULT; B CELL LYMPHOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; PROGNOSIS; REED STERNBERG CELL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOPSY; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; IMMUNE SYSTEM; LYMPH NODES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 35148885741     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701573216     Document Type: Letter

References (13)

1. Carbonne, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W. and Tubiana, M. (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res, 31, pp. 1860-1861.
2. World Health Organization (1999) Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory comittee meeting-Airlie House, Virginia, November, 1997. J Clin Oncol, 17, pp. 3835-3849.
3. Basu, D. and Roy, S. K. (2006) Interfollicular Hodgkin's disease: An uncommon pattern that may cause diagnostic difficulty. Ind J Pathol Microbiol, 49, pp. 221-225.
4. Ribera, J. M., Navarro, J. T., Oriol, A., López-Guillermo, A., Sureda, A. and Abella, E. (2002) Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease. AIDS, 16, pp. 1973-1976.
5. Hoffmann, C., Chow, K. U., Wolf, E., Faetkenheuer, G., Stellbrink, H. J. and Van Lunzen, J. (2004) Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol, 125, pp. 455-462.
6. Antinori, A., Cingolani, A., Alba, L., Ammassari, A., Serraino, D. and Ciancio, B. C. (2001) Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS, 15, pp. 1483-1491.
7. Oksenhendler, E., Clauvel, J., Juoveshomme, S., Davi, S. and Mansour, G. (1998) Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol, 57, p. 266.
8. Fatkenheuer, G., Hell, K., Roers, A., Diehl, V. and Salzberger, B. (2000) Spontaneus regression of HIV-associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy. Eur J Med Res, 5, pp. 236-240.
9. Centers for Disease Control (1992) 1993 Revised classification system for HIV infection and expands surveillance case definition for AIDS adolescents and adults. MMWR, 41, pp. 1-18.
10. Hewavisenthi, S. J. and Wedsinghe, A. N. (2000) Interfollicular Hodgkin's disease with histological features of Castelman's disease. Ceylon Med J, 45, pp. 138-139.
11. Anetto, U., Pafani, F DP and Perez, C. (2005) Interfollicular Hodgkin's lymphoma and Castleman's disease. Histopathology, 48, pp. 317-319.
12. Lister, T. A., Crowther, D., Sutcliffe, S. B., Glatstein, E., Canellos, G. P. and Young, R. C. (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Costwolds meeting. J Clin Oncol, 7, pp. 1630-1636.
13. Juweid, M., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M. and Guermazi, A. (2007) Use of positron emission tomography for response assessment of Lymphoma: Consensus of the imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol, 25, pp. 571-578.